RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy [m6A-seq]
Ontology highlight
ABSTRACT: RNA N6-methyladenosine methyltransferase METTL3 drives NAFLD-HCC and is a therapeutic target for boosting immunotherapy [m6A-seq]
PROVIDER: PRJNA978024 | ENA |
REPOSITORIES: ENA
ACCESS DATA